Literature DB >> 8956018

Treating anemia.

K E King1, P M Ness.   

Abstract

Transfusion therapy is frequently used in the treatment of sickle cell disease and its complications, but its efficacy has not been well proven. Red cell transfusions are well established for the acute treatment of cerebrovascular accidents and for the prevention of their recurrence. Acute chest syndrome with respiratory insufficiency is also an established indication for transfusion, especially in children. The use of red cell transfusions, especially chronic transfusions, in the treatment of sickle cell disease should be initiated only after serious consideration of the clinical setting and possible adverse effects. Both risks and benefits should be discussed with the patient, and that discussion should be documented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956018     DOI: 10.1016/s0889-8588(05)70402-0

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  1 in total

Review 1.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.